We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
-13.97%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.32B
AUM Growth
-$464M
Cap. Flow
-$25.6M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.12%
Holding
3,389
New
307
Increased
403
Reduced
666
Closed
334

Sector Composition

Rank Sector Weight
1 Technology 17.28%
2 Financials 9.97%
3 Healthcare 9.54%
4 Consumer Discretionary 9.4%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYTM icon
3201
Rhythm Pharmaceuticals
RYTM
$8.19B
-3,454
Closed -$40K
SCOR icon
3202
Comscore
SCOR
$90.6M
-216
Closed -$13K
SERA icon
3203
Sera Prognostics
SERA
$78.3M
-365
Closed -$1K
SLDB icon
3204
Solid Biosciences
SLDB
$990M
-315
Closed -$6K
SMMT icon
3205
Summit Therapeutics
SMMT
$11.5B
-1,762
Closed -$4K
SMSI icon
3206
Smith Micro Software
SMSI
$16.8M
-74
Closed -$11K
FTH
3207
Faeth Therapeutics
FTH
$767M
-80
Closed -$4K
SOPA
3208
DELISTED
Society Pass
SOPA
-16
Closed -$1K
SPRO icon
3209
Spero Therapeutics
SPRO
$71.8M
-1,713
Closed -$15K
SPRU icon
3210
Spruce Power Holding Corp
SPRU
$33.1M
-1,161
Closed -$18K
SPRY icon
3211
ARS Pharmaceuticals
SPRY
$614M
-1,032
Closed -$4K
SRRK icon
3212
Scholar Rock
SRRK
$6.52B
-2,162
Closed -$28K
STIM icon
3213
Neuronetics
STIM
$225M
-1,958
Closed -$6K
STTK icon
3214
Shattuck Labs
STTK
$736M
-2,086
Closed -$9K
STXS icon
3215
Stereotaxis
STXS
$138M
-3,905
Closed -$15K
SYRE icon
3216
Spyre Therapeutics
SYRE
$9B
-148
Closed -$9K
TCRT icon
3217
Alaunos Therapeutics
TCRT
$4.88M
-126
Closed -$12K
TERN
3218
DELISTED
Terns Pharmaceuticals
TERN
-708
Closed -$2K
TISI icon
3219
Team
TISI
$101M
-241
Closed -$5K
TNXP icon
3220
Tonix Pharmaceuticals
TNXP
$214M
0
-$6K
TOON icon
3221
Kartoon Studios
TOON
$38.4M
-2,213
Closed -$23K
TRDA icon
3222
Entrada Therapeutics
TRDA
$288M
-708
Closed -$7K
TSAT icon
3223
Telesat
TSAT
$795M
-553
Closed -$9K
TSHA icon
3224
Taysha Gene Therapies
TSHA
$1.92B
-1,745
Closed -$11K
TXMD icon
3225
TherapeuticsMD
TXMD
$24.1M
-549
Closed -$10K

Similar funds

Ameritas Investment Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Ameritas Investment Partners held 3,389 positions worth $2.32B, down 17% from $2.78B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2022 filing shows 307 new, 403 increased, 666 reduced and 334 closed positions. Its largest new stake was Aspen Technology Inc: 7,496 shares worth $1.38M. The largest sale was Camden Property Trust, an estimated $4.85M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Ameritas Investment Partners's largest Q2 2022 buy was Aspen Technology Inc: 7,496 shares worth $1.38M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q2 2022, an estimated $3.81M increase.
  • Ameritas Investment Partners's biggest Q2 2022 reduction was Camden Property Trust, cutting an estimated $4.85M.
  • Ameritas Investment Partners fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $2.95M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.32B portfolio in Q2 2022.
  • Ameritas Investment Partners opened 307 new positions and closed 334 in Q2 2022.
  • Ameritas Investment Partners's portfolio value fell 17% quarter-over-quarter to $2.32B.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.